abstract |
The present disclosure relates to novel compounds useful as inhibitors of the proteasome and pharmaceutical compositions thereof. The compounds provided herein have improved proteasome efficacy and selectivity, increased water solubility, and are useful for treating various diseases or disorders associated with the proteasome. |